- Home
- BMBL vs SANA Comparison
BMBL vs SANA Comparison
Compare BMBL & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMBL
- SANA
- Stock Information
- Founded
- BMBL 2014
- SANA 2018
- Country
- BMBL United States
- SANA United States
- Employees
- BMBL N/A
- SANA N/A
- Industry
- BMBL Computer Software: Prepackaged Software
- SANA Medicinal Chemicals and Botanical Products
- Sector
- BMBL Technology
- SANA Health Care
- Exchange
- BMBL Nasdaq
- SANA Nasdaq
- Market Cap
- BMBL 756.3M
- SANA 1.1B
- IPO Year
- BMBL 2021
- SANA 2021
- Fundamental
- Price
- BMBL $6.78
- SANA $5.04
- Analyst Decision
- BMBL Buy
- SANA Strong Buy
- Analyst Count
- BMBL 18
- SANA 3
- Target Price
- BMBL $9.30
- SANA $13.67
- AVG Volume (30 Days)
- BMBL 4.1M
- SANA 1.3M
- Earning Date
- BMBL 08-07-2024
- SANA 11-06-2024
- Dividend Yield
- BMBL N/A
- SANA N/A
- EPS Growth
- BMBL N/A
- SANA N/A
- EPS
- BMBL 0.31
- SANA N/A
- Revenue
- BMBL $1,085,537,000.00
- SANA N/A
- Revenue This Year
- BMBL $3.63
- SANA N/A
- Revenue Next Year
- BMBL $0.64
- SANA N/A
- P/E Ratio
- BMBL $21.95
- SANA N/A
- Revenue Growth
- BMBL 11.11
- SANA N/A
- 52 Week Low
- BMBL $4.80
- SANA $2.75
- 52 Week High
- BMBL $16.25
- SANA $12.00
- Technical
- Relative Strength Index (RSI)
- BMBL 44.06
- SANA 40.19
- Support Level
- BMBL $6.53
- SANA $5.57
- Resistance Level
- BMBL $7.09
- SANA $6.34
- Average True Range (ATR)
- BMBL 0.30
- SANA 0.38
- MACD
- BMBL 0.16
- SANA -0.01
- Stochastic Oscillator
- BMBL 71.95
- SANA 10.34
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.